Form 8-K

8-K — ALBEMARLE CORP

Accession: 0000915913-26-000101

Filed: 2026-08-05

Period: 2026-08-05

CIK: 0000915913

SIC: 2821 (PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — alb-20260805.htm (Primary)

EX-99.1 (a2q26earningsreleaseex991.htm)

GRAPHIC (alb-mainxreg4xx100.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: alb-20260805.htm · Sequence: 1

alb-20260805

false000091591300009159132026-08-052026-08-050000915913us-gaap:CommonStockMember2026-08-052026-08-050000915913us-gaap:SeriesAPreferredStockMember2026-08-052026-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________

FORM 8-K

_________________________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) August 5, 2026

_________________________________

ALBEMARLE CORPORATION

(Exact name of Registrant as specified in charter)

_________________________________

Virginia 001-12658 54-1692118

(State or other jurisdiction

of incorporation) (Commission

file number) (IRS employer

identification no.)

4250 Congress Street, Suite 900

Charlotte, North Carolina 28209

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code

(980) 299-5700

Not applicable

(Former name or former address, if changed since last report)

_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered

COMMON STOCK, $.01 Par Value ALB New York Stock Exchange

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock ALB PR A New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section 2 - Financial Information

Item 2.02. Results of Operations and Financial Condition.

On August 5, 2026, Albemarle Corporation (the “Company”) issued a press release reporting its results for the second quarter ended June 30, 2026. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on August 6, 2026, the Company will hold a teleconference for analysts and media to discuss results for the second quarter ended June 30, 2026. The teleconference will be webcast on the Company’s website at www.albemarle.com.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Section 9 - Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number Exhibit

99.1

Press release, dated August 5, 2026 issued by the Company.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 5, 2026

ALBEMARLE CORPORATION

By: /s/ Neal R. Sheorey

Neal R. Sheorey

Executive Vice President and Chief Financial Officer

EX-99.1

Filename: a2q26earningsreleaseex991.htm · Sequence: 2

Document

Exhibit 99.1

Contact:

invest@albemarle.com 1.980.308.6194

Albemarle Reports Second Quarter 2026 Results

CHARLOTTE, N.C. – August 5, 2026 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2026.

Second Quarter 2026 and Recent Highlights

(Unless otherwise stated, all percentage changes represent year-over-year comparisons and do not exclude the prior-period results of Ketjen’s refining catalyst solutions business in which the company sold a 51% stake on March 2, 2026)

•Net sales of $1.7 billion, up 31% due to higher pricing in Energy Storage (+73%) and higher pricing and volumes in Specialties (price +11%, volume +8%).

•Net income of $480 million, or $3.52 per diluted share attributable to common shareholders.

•Adjusted EBITDA(a) of $858 million; up 155% due primarily to higher pricing in Energy Storage, increased pricing and volumes in Specialties and ongoing cost and productivity improvements. Adjusted EBITDA expanded in both Energy Storage (+229%) and Specialties (+61%).

•Cash from operating activities of $710 million and free cash flow of $638 million(a). Operating cash flow conversion of 83%(a), primarily driven by timing of an increased dividend from the Talison joint venture and non-recurring working capital benefits.

•Delivered $100 million in year-to-date run-rate cost and productivity improvements, tracking towards the high end of our full-year target of $100 to $150 million.

•Improving full-year 2026 outlook considerations including:

◦Increasing full-year Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA outlook to $275 to $325 million, due to stronger-than-expected pricing and volume performance year to date.

◦Expect minimal impact to Energy Storage sales volume related to the fire at Talison CGP3 which occurred on June 9, in part due to better-than-planned output from the Wodgina mine.

◦Reducing full-year capital expenditure forecast to approximately $500 million due to ongoing capital efficiency improvements.

(a) See Non-GAAP Reconciliations for further details.

“Albemarle delivered another quarter of strong results, reflecting improved pricing, continued strength in Specialties, disciplined cost and productivity execution, and strong cash generation,” said Kent Masters, Chairman and CEO. “We continue to see resilient demand fundamentals across our core markets, including energy storage, electric vehicles, and semiconductors. We are advancing our highest value organic growth opportunities while maintaining a disciplined approach to capital allocation and execution.”

Second Quarter 2026 Results

In millions, except per share amounts Q2 2026 Q2 2025 $ Change % Change

Net sales $ 1,743.3 $ 1,330.0 $ 413.3 31.1 %

Net income attributable to Albemarle Corporation $ 480.0 $ 22.9 $ 457.1 1,996.2 %

Adjusted EBITDA(a)

$ 858.1 $ 336.5 $ 521.6 155.0 %

Diluted income (loss) per share attributable to common shareholders $ 3.52 $ (0.16) $ 3.68 NM

Non-recurring and other unusual items(a)

0.22 0.27

Adjusted diluted income per share attributable to common shareholders(a)(b)

$ 3.75 $ 0.11 $ 3.64 NM

(a) See Non-GAAP Reconciliations for further details.

(b) Totals may not add due to rounding.

Net sales for the second quarter of 2026 were $1.7 billion compared to $1.3 billion for the prior-year quarter, up 31%, driven primarily by higher prices in both Energy Storage and Specialties and volume growth in Specialties. Adjusted EBITDA of $858 million increased by $522 million from the prior-year quarter, primarily due to higher net sales and ongoing cost and productivity improvements.

Net income attributable to Albemarle of $480 million increased year over year by $457 million. The effective income tax rate for the second quarter of 2026 was 21.3% or 19.1% on an adjusted basis.

Energy Storage Results

In millions Q2 2026 Q2 2025 $ Change % Change

Net Sales $ 1,276.7 $ 717.7 $ 559.0 77.9 %

Sales Volume (kT LCE)(a)

65 59 6 11.0 %

Avg. Realized Price ($/kg LCE)(a)

$ 19.53 $ 12.17 $ 7.36 60.5 %

Adjusted EBITDA $ 723.5 $ 219.7 $ 503.7 229.3 %

(a) Includes aggregated salts and spodumene sales on a lithium carbonate equivalent (LCE) basis.

Energy Storage net sales for the second quarter of 2026 were $1.3 billion, an increase of $559 million, or 78%, due to higher pricing. Adjusted EBITDA of $723 million increased $504 million, or 229%, primarily due to higher lithium pricing partially offset by higher CORFO commissions.

Specialties Results

In millions Q2 2026 Q2 2025 $ Change % Change

Net Sales $ 423.5 $ 351.6 $ 71.9 20.5 %

Adjusted EBITDA $ 117.7 $ 73.0 $ 44.7 61.3 %

Specialties net sales for the second quarter of 2026 were $423 million, an increase of $72 million, or 20%, primarily due to higher volumes (+8%) and pricing (+11%). Adjusted EBITDA of $118 million increased $45 million, or 61%, primarily due to higher volumes and favorable pricing in bromine and derivatives, along with continued productivity improvements and proactive management of cost escalations driven by the conflict in the Middle East.

2026 Outlook Considerations

Total Corporate Outlook Considerations

The table below reflects expected outcomes for the total company based on recently observed lithium market price scenarios. Outlook ranges for each scenario are based on variation in sales volume and product mix. Energy Storage production volumes are expected to increase year over year. Sales volumes are expected to be in the range of 225 to 235 kilotons lithium carbonate equivalent, as increased Wodgina volumes partially offset a delay in the Talison CGP3 ramp due to a fire that occurred on June 9. All three scenarios assume flat market pricing flowing through Energy Storage’s current contract book which includes approximately 40% of salts volume (or one-third of total volumes) on long-term agreements. Scenarios also assume that spodumene pricing averages 10% of the lithium carbonate equivalent (LCE) price, while other costs are assumed to be constant.

Total Corporate FY 2026E

Observed market price case(a)

FY 2025 avg. Q1 2026 avg. 2021-2025 avg.

Average lithium market price ($/kg LCE)(a)

~$10 ~$20 ~$30

Net sales $4.1 - $4.3 billion $5.7 - $6.0 billion $7.5 - $7.8 billion

Adjusted EBITDA(b)

$0.9 - $1.0 billion $2.4 - $2.6 billion $4.2 - $4.4 billion

(a) Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

(b) The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See “Additional Information Regarding Non-GAAP Measures” for more information.

Energy Storage Market Price Scenarios

Energy Storage FY 2026E

Observed market price case(a)

FY 2025 avg. Q1 2026 avg. 2021-2025 avg.

Average lithium market price ($/kg LCE)(a)

~$10 ~$20 ~$30

Net sales $2.5 - $2.6 billion $4.0 - $4.2 billion $5.9 - $6.1 billion

Adjusted EBITDA $0.7 - $0.8 billion $2.1 - $2.3 billion $3.9 - $4.1 billion

Equity in net income of unconsolidated investments (net of tax)(b)

$0.2 - $0.3 billion $0.6 - $0.7 billion $1.0 - $1.1 billion

(a) Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

(b) Included in adjusted EBITDA on a pre-tax basis.

Specialties Outlook Considerations

Specialties net sales and adjusted EBITDA outlook is improved primarily due to strong year to date performance driven by volume growth in bromine specialties and cost and productivity improvements. Our outlook continues to reflect modest volume growth in key end markets led by semiconductors, oil and gas, flame retardants and pharmaceuticals partially offset by expected softness in automotive and petrochemicals. Second-half outlook assumes stabilization in the bromine market and continued uncertainties including the situation in the Middle East. Operations at the Jordan Bromine Company (JBC) joint venture are in line with expectations as it continues to navigate geopolitical tensions in the region.

Segment FY 2026E

Specialties net sales $1.4 - $1.6 billion

Specialties adjusted EBITDA $275 - $325 million

Other Corporate Outlook Considerations

Albemarle expects its full-year 2026 capital expenditures to be approximately $500 million, down 15% compared to 2025 due to ongoing capital efficiency improvements.

Following the sale of a controlling stake in Ketjen’s refining catalyst solutions business, announced on March 2, 2026, the refining catalyst business earnings are now classified as equity income and included in Corporate, as are the results of the retained Performance Catalyst Solutions (PCS) business. The adjusted EBITDA and equity income contributions from these are expected to be immaterial post transaction.

Interest and financing expense is expected to be between $120 and $140 million for 2026 following the debt reduction actions completed in the first quarter of 2026.

Other Corporate FY 2026E

Capital expenditures ~$500 million

Depreciation and amortization $660 - $680 million

Adjusted effective tax rate(a)

(50)% - 30%

Corporate adjusted EBITDA (incl. FX, Ketjen equity income & PCS) ($20) - $20 million

Interest and financing expenses $120 - $140 million

Weighted-average common shares outstanding (diluted)(b)

~136 million

(a) Adjusted effective tax rate dependent on lithium market prices and geographic income mix

(b) Diluted weighted-average common shares outstanding amount assumes the conversion of preferred stock and the net income attributable to common shareholders will not be reduced by mandatory convertible preferred stock dividends. If the reduction of mandatory convertible preferred stock dividends results in a more dilutive earnings per share, the diluted weighted-average common shares outstanding will not assume conversion of the preferred stock.

Cash Flow and Capital Deployment

Cash from operations of $1.1 billion in the first half of 2026 increased $518 million compared to the prior-year period. Capital expenditures of $170 million in the first six months of 2026 decreased by $132 million versus the prior-year period.

Balance Sheet and Liquidity

As of June 30, 2026, Albemarle had estimated liquidity of approximately $3.2 billion, including $1.6 billion of cash and cash equivalents, $1.5 billion available under our revolver and $78 million available under other credit lines. Total debt was $1.9 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 0.5(a).

(a) See Non-GAAP Reconciliations for further details.

Earnings Call

Date: Thurs., August 6, 2026

Time: 8:00 AM Eastern time

Dial-in (U.S.): 1-800-590-8290

Dial-in (International): 1-240-690-8800

Conference ID: ALBQ2

The company’s earnings presentation and supporting material are available on Albemarle’s website at https://investors.albemarle.com.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

Forward-Looking Statements

This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as “ambition,” “anticipate,” “believe,” “estimate,” “expect,” “goal,” “guidance,” “intend,” “may,” “outlook,” “scenario,” “should,” “would,” and “will.” Forward-looking statements may include statements regarding: our 2026 company and segment outlooks, including expected market pricing of lithium carbonate equivalent and spodumene and other underlying assumptions and outlook consideration; plans and expectations regarding customer demand and sales; production impacts; financial flexibility and optionality; expected or actual market pricing of lithium, spodumene, bromine, and lithium specialties (“Company Products”); supply and demand for Company Products; drivers of long-term demand and growth; other underlying assumptions and outlook considerations; expected capital allocation and expenditure amounts and the corresponding impact on cash flow; expected impact of tariffs and other trade restrictions; plans and expectations regarding other mining interests, resources, reserves, projects and activities, compound annual growth rate, cost reductions, conversion network optimization, margin improvement, accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle’s actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; changes in trade policies and tariffs; and the financial and operating performance of customers; timing and magnitude of customer orders; fluctuations in market pricing of lithium carbonate equivalent and spodumene; potential production volume shortfalls; increased competition and pressure to renegotiate contract terms; changes in product or conversion demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; risks related to the integration of artificial intelligence technologies into our operations; geopolitical conflicts and political unrest affecting global trade, including tensions in the Middle East; the global economy and clean energy initiatives; our ability to retain key personnel and attract new skilled personnel changes in inflation or interest rates; volatility and uncertainties in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; expected benefits and expenses from new operating structure and asset optimization activities; performance of Albemarle’s partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under “Risk Factors” in Albemarle’s most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle’s website (investors.albemarle.com) and on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Albemarle Corporation and Subsidiaries

Consolidated Statements of Income

(In Thousands Except Per Share Amounts) (Unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2026 2025 2026 2025

Net sales $ 1,743,313 $ 1,329,992 $ 3,172,044 $ 2,406,873

Cost of goods sold 1,153,012 1,133,116 2,080,777 2,053,698

Gross profit 590,301 196,876 1,091,267 353,175

Selling, general and administrative expenses 126,353 132,457 263,759 255,959

Restructuring charges and asset write-offs 7,337 4,448 33,203 3,385

Research and development expenses 3,667 12,444 12,837 26,543

Loss on sale of business — — 95,018 —

Operating income 452,944 47,527 686,450 67,288

Interest and financing expenses (30,924) (49,939) (64,045) (98,916)

Other income (expenses), net 19,629 (6,559) 73,439 3,691

Income (loss) before income taxes and equity in net income of unconsolidated investments 441,649 (8,971) 695,844 (27,937)

Income tax expense 94,002 34,094 115,513 30,116

Income (loss) before equity in net income of unconsolidated investments 347,647 (43,065) 580,331 (58,053)

Equity in net income of unconsolidated investments (net of tax) 151,564 78,258 247,857 142,544

Net income 499,211 35,193 828,188 84,491

Net income attributable to noncontrolling interests (19,252) (12,296) (29,138) (20,246)

Net income attributable to Albemarle Corporation 479,959 22,897 799,050 64,245

Mandatory convertible preferred stock dividends (41,687) (41,687) (83,375) (83,375)

Net income (loss) attributable to Albemarle Corporation common shareholders $ 438,272 $ (18,790) $ 715,675 $ (19,130)

Basic earnings (loss) per share attributable to common shareholders $ 3.72 $ (0.16) $ 6.07 $ (0.16)

Diluted earnings (loss) per share attributable to common shareholders $ 3.52 $ (0.16) $ 5.87 $ (0.16)

Weighted-average common shares outstanding – basic 117,961 117,665 117,907 117,634

Weighted-average common shares outstanding – diluted 136,212 117,665 136,170 117,634

Albemarle Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(In Thousands) (Unaudited)

June 30, December 31,

2026 2025

ASSETS

Current assets:

Cash and cash equivalents $ 1,631,688 $ 1,618,001

Trade accounts receivable 603,805 593,502

Other accounts receivable 123,870 105,110

Inventories 1,384,563 1,179,271

Other current assets 200,275 140,440

Current assets held for sale — 371,815

Total current assets

3,944,201 4,008,139

Property, plant and equipment 11,902,156 11,768,840

Less accumulated depreciation and amortization 3,442,831 3,156,429

Net property, plant and equipment

8,459,325 8,612,411

Investments 1,109,241 900,926

Other assets 707,577 647,185

Goodwill 1,482,672 1,499,657

Other intangibles, net of amortization 202,079 214,233

Noncurrent assets held for sale — 491,660

Total assets $ 15,905,095 $ 16,374,211

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable to third parties $ 670,229 $ 779,160

Accounts payable to related parties 445,421 134,369

Accrued expenses 507,556 521,831

Current portion of long-term debt 74,677 74,077

Dividends payable 61,514 61,387

Income taxes payable 131,703 35,467

Current liabilities held for sale — 191,753

Total current liabilities

1,891,100 1,798,044

Long-term debt 1,802,107 3,119,464

Postretirement benefits 45,198 44,744

Pension benefits 105,729 117,361

Other noncurrent liabilities 1,158,555 1,084,892

Deferred income taxes 368,552 368,275

Noncurrent liabilities held for sale — 59,970

Commitments and contingencies

Equity:

Albemarle Corporation shareholders’ equity:

Common stock 1,180 1,178

Mandatory convertible preferred stock 2,235,105 2,235,105

Additional paid-in capital 3,048,664 3,018,213

Accumulated other comprehensive loss (243,599) (334,807)

Retained earnings 5,233,819 4,613,676

Total Albemarle Corporation shareholders’ equity 10,275,169 9,533,365

Noncontrolling interests 258,685 248,096

Total equity 10,533,854 9,781,461

Total liabilities and equity $ 15,905,095 $ 16,374,211

Albemarle Corporation and Subsidiaries

Selected Consolidated Cash Flow Data

(In Thousands) (Unaudited)

Six Months Ended

June 30,

2026 2025

Cash and cash equivalents at beginning of year $ 1,618,001 $ 1,192,230

Cash flows from operating activities:

Net income 828,188 84,491

Adjustments to reconcile net income to cash flows from operating activities:

Depreciation and amortization 313,606 330,485

Loss on sale of business 95,018 —

Gain on sale of equity investment (42,300) —

Stock-based compensation and other 14,661 17,068

Equity in net income of unconsolidated investments (net of tax) (247,857) (142,544)

Dividends received from unconsolidated investments and nonmarketable securities 131,744 67,765

Pension and postretirement expense 5,299 3,504

Pension and postretirement contributions (14,298) (9,934)

Unrealized (gain) loss on investments in marketable securities (2,792) 4,984

Gain on early extinguishment of debt (12,543) —

Deferred income taxes (19,798) (38,907)

Working capital changes (53,125) (96,762)

Noncurrent liability changes and other, net 60,438 318,030

Net cash provided by operating activities 1,056,241 538,180

Cash flows from investing activities:

Capital expenditures (170,407) (302,252)

Proceeds from sale of businesses, net of cash sold 525,156 —

Proceeds from sale of property and equipment — 23,751

Proceeds from sale of investments 123,270 —

Proceeds from sale of available for sale debt securities — 288,000

(Payments) proceeds from settlement of foreign currency forward contracts, net (18,772) 171,262

Sales of marketable securities, net 1,392 2,971

Investments in equity investments and nonmarketable securities (119) (120)

Net cash provided by investing activities 460,520 183,612

Cash flows from financing activities:

Repayments of long-term debt and credit agreements (1,314,151) (29,103)

Proceeds from borrowings of long-term debt and credit agreements 35,952 19,488

Other debt repayments, net (12,309) (2,427)

Fees related to early extinguishment of debt (1,686) —

Dividends paid to common shareholders (95,372) (95,244)

Dividends paid to mandatory convertible preferred shareholders (83,375) (83,375)

Dividends paid to noncontrolling interests (37,463) (18,169)

Proceeds from exercise of stock options 19,635 1,186

Withholding taxes paid on stock-based compensation award distributions (4,199) (2,941)

Other (438) (55)

Net cash used in financing activities (1,493,406) (210,640)

Net effect of foreign exchange on cash and cash equivalents (9,668) 103,447

Increase in cash and cash equivalents 13,687 614,599

Cash and cash equivalents at end of period $ 1,631,688 $ 1,806,829

Albemarle Corporation and Subsidiaries

Consolidated Summary of Segment Results

(In Thousands) (Unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2026 2025 2026 2025

Net sales:

Energy Storage $ 1,276,684 $ 717,656 $ 2,167,849 $ 1,242,221

Specialties 423,484 351,560 781,897 672,574

Total segment net sales 1,700,168 1,069,216 2,949,746 1,914,795

Corporate and all other 43,145 260,776 222,298 492,078

Total net sales $ 1,743,313 $ 1,329,992 $ 3,172,044 $ 2,406,873

Adjusted EBITDA:

Energy Storage $ 723,457 $ 219,725 $ 1,274,813 $ 406,080

Specialties 117,720 72,977 193,849 131,643

Total segment adjusted EBITDA 841,177 292,702 1,468,662 537,723

Corporate and all other 16,920 43,773 53,249 65,896

Total adjusted EBITDA $ 858,097 $ 336,475 $ 1,521,911 $ 603,619

See accompanying non-GAAP reconciliations below.

Additional Information Regarding Non-GAAP Measures

It should be noted that adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, adjusted diluted income (loss) per share attributable to common shareholders, non-operating pension and other post-employment benefit (“OPEB”) items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin, adjusted EBITDA margin, operating cash flow conversion and net debt to adjusted EBITDA ratio are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net income attributable to Albemarle Corporation (“earnings”) or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company’s operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company’s chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.

A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle’s website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.

ALBEMARLE CORPORATION AND SUBSIDIARIES

Non-GAAP Reconciliations

(Unaudited)

See below for a reconciliation of adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net income attributable to Albemarle Corporation is defined as net income attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net income (loss) attributable to Albemarle Corporation common stockholders is defined as adjusted net income attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net income attributable to Albemarle Corporation before interest and financing expenses, income tax expense (benefit), and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring and other unusual items, and non-operating pension and OPEB items as listed below.

Three Months Ended Six Months Ended

June 30, June 30,

2026 2025 2026 2025

In thousands, except percentages and per share amounts $ % of net sales $ % of net sales $ % of net sales $ % of net sales

Net income attributable to Albemarle Corporation $479,959

$ 22,897

$ 799,050

$ 64,245

Add back:

Non-operating pension and OPEB items (net of tax) 626

169

1,597

294

Non-recurring and other unusual items (net of tax) 30,555

31,708

111,945

10,508

Adjusted net income attributable to Albemarle Corporation 511,140

54,774

912,592

75,047

Mandatory convertible preferred stock dividends(a)

— (41,687) — (83,375)

Adjusted net income (loss) attributable to Albemarle Corporation common shareholders $511,140 $ 13,087 $ 912,592 $ (8,328)

Adjusted diluted income (loss) per share attributable to common shareholders $ 3.75

$ 0.11

$ 6.70

$ (0.07)

Adjusted weighted-average common shares outstanding – diluted(a)

136,212 117,691 136,170 117,634

Net income attributable to Albemarle Corporation $479,959 27.5 %

$ 22,897 1.7 %

$ 799,050 25.2 %

$ 64,245 2.7 %

Add back:

Interest and financing expenses 30,924 1.8 %

49,939 3.8 %

64,045 2.0 %

98,916 4.1 %

Income tax expense 94,002 5.4 %

34,094 2.6 %

115,513 3.6 %

30,116 1.3 %

Depreciation and amortization 155,801 8.9 %

168,731 12.7 %

313,606 9.9 %

330,485 13.7 %

EBITDA 760,686 43.6 %

275,661 20.7 %

1,292,214 40.7 %

523,762 21.8 %

Proportionate share of Windfield income tax expense 70,766 4.1 % 33,150 2.5 % 112,300 3.5 % 58,476 2.4 %

Non-operating pension and OPEB items 854 — %

336 — %

2,201 0.1 %

611 — %

Non-recurring and other unusual items 25,791 1.5 %

27,328 2.1 %

115,196 3.6 %

20,770 0.9 %

Adjusted EBITDA $858,097 49.2 %

$ 336,475 25.3 %

$ 1,521,911 48.0 %

$ 603,619 25.1 %

Net sales $ 1,743,313

$ 1,329,992

$ 3,172,044

$ 2,406,873

(a) Calculation of adjusted diluted income (loss) per share attributable to common shareholders for the three and six months ended June 30, 2026 excludes $41.7 million and $83.4 million, respectively, of mandatory convertible preferred stock dividends and includes the assumed conversion of preferred stock into the diluted shares outstanding, as this results in the more dilutive per share result.

Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle’s operating segments and are included in the Corporate and all other category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company’s businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other income (expenses), net. Non-operating pension and OPEB items were as follows (in thousands):

Three Months Ended Six Months Ended

June 30, June 30,

2026 2025 2026 2025

Interest cost $ 8,994 $ 8,924 $ 18,035 $ 17,734

Expected return on assets (8,140) (8,588) (15,834) (17,123)

Total $ 854 $ 336 $ 2,201 $ 611

In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle’s adjusted net income (loss) calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):

Three Months Ended Six Months Ended

June 30, June 30,

2026 2025 2026 2025

Restructuring charges and asset write-offs(1)

$ 0.05 $ 0.02 $ 0.24 $ 0.01

Acquisition and integration related costs(2)

0.01 0.01 0.01 0.02

Loss on sale of business/equity investment, net(3)

— — 0.39 —

Gain on early extinguishment of debt(4)

— — (0.09) —

(Gain) loss in fair value of public equity securities(5)

(0.05) — (0.01) 0.03

Other(6)

0.17 0.13 0.20 0.05

Tax related items(7)

0.04 0.11 0.08 (0.02)

Total non-recurring and other unusual items $ 0.22 $ 0.27 $ 0.82 $ 0.09

(1)In 2026, the Company announced it would place Kemerton Train 1 into care and maintenance. As a result, and in addition to other previously announced restructuring actions, the Company recorded charges of $7.3 million and $33.2 million in Restructuring charges and asset write-offs for the three and six months ended June 30, 2026, respectively. Due to the impact of valuation allowances, this resulted in total after-tax charges of $7.5 million and $33.3 million, or $0.05 and $0.24 per share, for the three and six months ended June 30, 2026, respectively. The three and six months ended June 30, 2025 included certain restructuring costs and adjustments to previously recorded costs related to restructuring actions originally entered into in 2024. As a result, the Company recorded charges of $4.4 million and $3.4 million in Restructuring charges and asset write-offs and gains (losses) of $0.1 million and ($0.1) million in Other income (expenses), net for the three and six months ended June 30, 2025, respectively. Due to the impact of valuation allowances, this resulted in total after-tax gains of $2.9 million and $0.8 million, or $0.02 and $0.01 per share, for the three and six months ended June 30, 2025, respectively.

(2)Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three and six months ended June 30, 2026 were $0.8 million and $1.9 million ($0.01 and $0.01 per share, with no income tax effect due to the impact of valuation allowances), respectively, and for the three and six months ended June 30, 2025 were $1.8 million and $3.2 million ($1.4 million and $2.5 million after income taxes, or $0.01 and $0.02 per share), respectively.

(3)During the first quarter of 2026, the Company divested its controlling ownership interest in its Refining Solutions business and its full 50% ownership interest in the Eurecat joint venture. As a result of these transactions, the Company recorded a net loss of $52.7 million ($0.39 per share, with no income tax effect due to the impact of valuation allowances), representing the proceeds received less the carrying value as of the transaction dates.

(4)During the first quarter of 2026, the Company completed a $1.3 billion debt tender and redemption, resulting in a gain on early extinguishment of debt of $12.5 million ($0.09 per share, with no income tax effect due to the impact of valuation allowances), representing the repurchase of this debt at a discount, partially offset by tender premiums and redemption fees.

(5)Gains resulting from the net change in fair value of investments in public equity securities, recorded in Other income (expenses), net for the three and six months ended June 30, 2026 of $6.5 million and $1.0 million ($0.05 and $0.01 per share, with no income tax effect due to the impact of valuation allowances), respectively, and for the three and six months ended June 30, 2025 gains (losses) of $0.2 million and ($4.8) million ($0.1 million and ($3.8 million) after income taxes, or less than $0.01 and $0.03 per share), respectively.

(6)Other adjustments for the three months ended June 30, 2026 included amounts recorded in:

•Cost of goods sold - $3.9 million of expenses related to non-routine labor and compensation related costs that are outside normal compensation arrangements.

•Selling, general and administrative expenses - Primarily comprised of $19.0 million of expenses, mainly consulting fees, related to the Company's strategic cost savings initiative.

•Other income (expenses), net - Primarily related to $3.4 million of charges for asset retirement obligations at a site not part of our operations and a net loss of $1.5 million primarily driven by indemnification charges related to the Eurecat S.A. joint venture sale, partially offset by a $3.9 million gain resulting from the adjustment of indemnification related to previously disposed businesses.

After income taxes, these net losses totaled $22.8 million, or $0.17 per share.

Other adjustments for the three months ended June 30, 2025 included amounts recorded in:

•Selling, general and administrative expenses - $8.3 million of gains from the sale of assets not part of our production operations, partially offset by $1.8 million of severance expenses not related to a restructuring plan.

•Other income (expenses), net - $38.0 million loss resulting from the redemption of preferred equity in a Grace subsidiary, partially offset by $10.1 million of income from PIK dividends of that preferred equity prior to redemption.

After income taxes, these net losses totaled $15.3 million, or $0.13 per share.

Other adjustments for the six months ended June 30, 2026 included amounts recorded in:

•Cost of goods sold - $3.9 million of expenses related to non-routine labor and compensation related costs that are outside normal compensation arrangements.

•Selling, general and administrative expenses - Primarily comprised of $19.0 million of expenses, mainly consulting fees, related to the Company's strategic cost savings initiative and a $3.9 million charge for a non-income tax audit of a facility no longer controlled by the Company.

After income taxes, these net losses totaled $27.0 million, or $0.20 per share.

Other adjustments for the six months ended June 30, 2025 included amounts recorded in:

•Selling, general and administrative expenses - $11.4 million of gains from the sale of assets not part of our production operations, partially offset by $1.8 million of severance expenses not related to a restructuring plan and $0.6 million of expenses related to certain historical legal matters.

•Other income (expenses), net - $38.0 million loss resulting from the redemption of preferred equity in a Grace subsidiary and $1.9 million of charges for asset retirement obligations at a site not part of our operations, partially offset by $19.8 million of income from PIK dividends of the preferred equity in a Grace subsidiary prior to redemption and a $1.9 million gain primarily resulting from the adjustment of indemnification related to previously disposed businesses.

After income taxes, these net losses totaled $5.4 million, or $0.05 per share.

(7)Included in Income tax expense for the three and six months ended June 30, 2026 are discrete net tax expenses of $6.0 million and $10.6 million, or $0.04 and $0.08 per share, respectively, primarily related to the impact of foreign tax reserves and foreign return to provisions.

Included in Income tax expense for the three and six months ended June 30, 2025 are discrete net tax expenses of $12.2 million, or $0.11 per share, and benefits of $2.0 million, or $0.02 per share,

respectively, primarily related to the impact of foreign tax reserves and excess tax benefits realized from stock-based compensation arrangements.

See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).

Income (loss) before income taxes and equity in net income of unconsolidated investments Income tax expense (benefit) Effective income tax rate

Three months ended June 30, 2026

As reported $ 441,649 $ 94,002 21.3 %

Non-recurring, other unusual and non-operating pension and OPEB items 26,691 (4,490)

As adjusted $ 468,340 $ 89,512 19.1 %

Three months ended June 30, 2025

As reported $ (8,971) $ 34,094 (380.0) %

Non-recurring, other unusual and non-operating pension and OPEB items 27,664 (4,213)

As adjusted $ 18,693 $ 29,881 159.9 %

Six months ended June 30, 2026

As reported $ 695,844 $ 115,513 16.6 %

Non-recurring, other unusual and non-operating pension and OPEB items 104,853 (8,689)

As adjusted $ 800,697 $ 106,824 13.3 %

Six months ended June 30, 2025

As reported $ (27,937) $ 30,116 (107.8) %

Non-recurring, other unusual and non-operating pension and OPEB items 21,381 10,579

As adjusted $ (6,556) $ 40,695 (620.7) %

See below for the calculation of operating cash flow conversion and a reconciliation of free cash flow, a non-GAAP measure, to net cash provided by operating activities, the most directly comparable financial measure calculated and reporting in accordance with GAAP. The Company defines operating cash flow conversion as Net cash provided by operating activities from the statement of cash flows divided by adjusted EBITDA, which is a non-GAAP measure. A reconciliation of adjusted EBITDA, the non-GAAP financial measure, from net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reporting in accordance with GAAP, is provided in the above tables (in thousands, except percentages).

Three Months Ended

June 30, 2026

Free cash flow:

Net cash provided by operating activities $ 709,997

Less: Capital expenditures (71,731)

Free cash flow $ 638,266

Operating cash flow conversion:

Net cash provided by operating activities $ 709,997

Adjusted EBITDA $ 858,097

Operating cash flow conversion 83 %

See below for the calculation of the net debt to adjusted EBITDA ratio (“Consolidated Leverage Ratio,” as defined in our credit agreement), a non-GAAP financial measure, for the twelve months ended June 30, 2026 (in thousands, except ratio).

Twelve Months Ended

June 30, 2026

Adjusted EBITDA $ 2,016,285

Equity in net income of non-Windfield Holdings unconsolidated investments (net of tax) 544

Dividends received from non-Windfield Holdings unconsolidated investments 9,804

Consolidated Windfield-Adjusted EBITDA $ 2,026,633

Total Albemarle Corporation long-term debt (as reported) $ 1,876,784

49% Windfield Holdings debt 718,079

Off-balance sheet obligations and other 95,200

Consolidated Windfield-Adjusted Funded Debt $ 2,690,063

Less Cash 1,631,688

Less 49% Windfield Holdings cash 62,249

Consolidated Windfield-Adjusted Funded Net Debt $ 996,126

Consolidated Leverage Ratio 0.5

GRAPHIC

Filename: alb-mainxreg4xx100.jpg · Sequence: 7

Binary file (144798 bytes)

Download alb-mainxreg4xx100.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Cover Document

Aug. 05, 2026

Cover [Abstract]

Document Type

8-K

Document Period End Date

Aug. 05, 2026

Entity Registrant Name

ALBEMARLE CORPORATION

Entity Incorporation, State or Country Code

Entity File Number

001-12658

Entity Tax Identification Number

54-1692118

Entity Address, Address Line One

4250 Congress Street, Suite 900

Entity Address, City or Town

Charlotte

Entity Address, State or Province

Entity Address, Postal Zip Code

28209

City Area Code

980

Local Phone Number

299-5700

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Amendment Flag

false

Entity Central Index Key

0000915913

Common Stock

Cover [Abstract]

Title of 12(b) Security

COMMON STOCK, $.01 Par Value

Trading Symbol

ALB

Security Exchange Name

NYSE

Document Information [Line Items]

Title of 12(b) Security

COMMON STOCK, $.01 Par Value

Trading Symbol

ALB

Security Exchange Name

NYSE

Series A Preferred Stock

Cover [Abstract]

Title of 12(b) Security

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock

Trading Symbol

ALB PR A

Security Exchange Name

NYSE

Document Information [Line Items]

Title of 12(b) Security

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock

Trading Symbol

ALB PR A

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: